JP4886122B2 - Vibrio parahaemolyticus detection medium - Google Patents

Vibrio parahaemolyticus detection medium Download PDF

Info

Publication number
JP4886122B2
JP4886122B2 JP2001165144A JP2001165144A JP4886122B2 JP 4886122 B2 JP4886122 B2 JP 4886122B2 JP 2001165144 A JP2001165144 A JP 2001165144A JP 2001165144 A JP2001165144 A JP 2001165144A JP 4886122 B2 JP4886122 B2 JP 4886122B2
Authority
JP
Japan
Prior art keywords
glucopyranoside
medium
vibrio parahaemolyticus
bromo
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2001165144A
Other languages
Japanese (ja)
Other versions
JP2002355091A (en
Inventor
哉 寺村
慎吾 水落
貞宣 韮塚
秀正 小高
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissui Seiyaku Co Ltd
Original Assignee
Nissui Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissui Seiyaku Co Ltd filed Critical Nissui Seiyaku Co Ltd
Priority to JP2001165144A priority Critical patent/JP4886122B2/en
Publication of JP2002355091A publication Critical patent/JP2002355091A/en
Application granted granted Critical
Publication of JP4886122B2 publication Critical patent/JP4886122B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【0001】
【発明の属する技術分野】
本発明は、食中毒の原因菌として重要な腸炎ビブリオを高精度かつ簡便に検出することのできる培地及び腸炎ビブリオ検出法に関する。
【0002】
【従来の技術】
腸炎ビブリオ(Vibrio parahaemolyticus)による食中毒は、日本で年間に発生する細菌性食中毒の大きな割合を占める。腸炎ビブリオは海水中に常在し、魚介類を生食することにより中毒が発生する。この食中毒は、急性胃腸炎であり、発熱、嘔吐、上腹部の腹痛、下痢を特徴とする。
【0003】
このような食中毒原因菌である腸炎ビブリオの検出培地としては、TCBS(Thiosulfate citrate bile salts sucrose)寒天培地が広く用いられている。このTCBS寒天培地は、白糖とpH指示薬を含むものであり、腸炎ビブリオが白糖を利用しないのに対し、ビブリオ属に属し、かつ食中毒の原因菌であるビブリオ・アルギノリティカス(Vibrio alginolyticus)やビブリオ・コレラ(Vibrio cholerae)等が白糖を利用して酸を生成するという性質を利用するものである。すなわち、発育してきた菌は菌体中にpH指示薬を取り込む。従って白糖を利用しない腸炎ビブリオ等はpH指示薬の色調変化がないため濃緑色のコロニーを形成するが、一方、白糖を利用し酸を生成する菌はpH指示薬が黄色に変色するため黄色のコロニーとなる、というものである。
【0004】
【発明が解決しようとする課題】
しかし、TCBS寒天培地においては、検体中に腸炎ビブリオと上記の類縁菌が共存した場合、腸炎ビブリオの濃緑色のコロニーが他の色に変色してしまうため、正確な検出ができなかった。
従って、本発明の目的は腸炎ビブリオと同じビブリオ属に属する類縁菌が共存しても色の変化等を生じずに、正確かつ簡便に腸炎ビブリオを検出できる培地を提供することにある。
【0005】
【課題を解決するための手段】
そこで本発明者は、腸炎ビブリオを他の属に属する菌だけでなく、同じ属に属する類縁菌とも正確に区別して検出できる培地組成について種々検討したところ、グラム陽性菌抗菌物質と検出可能な遊離性基を有するβ−グルコシダーゼ基質とを含有する培地を用いれば、グラム陽性菌は生育せず、かつビブリオ・アルギノリティカスやビブリオ・コレラは白色のコロニーを形成し、腸炎ビブリオが選択的にβ−グルコシダーゼ基質由来の特性を有するコロニーを形成するので、腸炎ビブリオが正確かつ簡便に検出できることを見出し、本発明を完成するに至った。
【0006】
すなわち、本発明は、検出可能な遊離性基を有するβ−グルコシダーゼ基質及びグラム陽性菌抗菌物質を含有する腸炎ビブリオ検出用培地を提供するものである。
また、本発明は上記培地に、検体を接種して培養した後、当該培地上の検出可能なコロニーの有無を検出することを特徴とする腸炎ビブリオの検出法を提供するものである。
【0007】
【発明の実施の形態】
本発明の培地に用いられる検出可能な遊離性基を有するβ−グルコシダーゼ基質とは、β−グルコシダーゼの作用によって色原体化合物、蛍光性化合物等の検出可能な化合物を培地中に遊離するものであり、例えば色原体化合物又は蛍光性化合物とβ−グルコースとが結合した化合物すなわち、色原体化合物又は蛍光性化合物を遊離し得るβ−グルコピラノシド又はその塩であればよい。腸炎ビブリオの類縁菌であるビブリオ・アルギノリティカスやビブリオ・コレラは、β−グルコシダーゼを分泌しないのに対し、腸炎ビブリオはβ−グルコシダーゼを分泌するので、このβ−グルコシダーゼ基質は、腸炎ビブリオによって分解され、色原体化合物、蛍光性化合物等の検出可能な化合物を遊離するため、腸炎ビブリオは色原体化合物に基づく着色コロニー、蛍光性化合物に基づく蛍光コロニー等の検出可能なコロニーを形成する。具体的なβ−グルコシダーゼ基質としては、5−ブロモ−4−クロロ−3−インドキシル−β−D−グルコピラノシド(X−β−グルコシド、青色)、5−ブロモ−6−クロロ−3−インドキシル−β−D−グルコピラノシド(MAGENTA−β−グルコピラノシド、赤紫)、5−ブロモ−6−クロロ−3−インドリル−β−D−グルコピラノシド(赤紫)、6−クロロ−3−インドリル−β−D−グルコピラノシド(ピンク)、5−ブロモ−3−インドリル−β−D−グルコピラノシド、4−メチル−ウンベリフェリル−β−D−グルコピラノシド、o−ニトロフェニル−β−D−グルコピラノシド、フェニル−β−D−グルコピラノシド、3−ニトロフェニル−β−D−グルコピラノシド、4−ニトロフェニル−β−D−グルコピラノシド、3−インドキシル−β−グルコピラノシドトリハイドレート、n−ヘプティル−β−D−グルコピラノシド、5−ブロモ−4−クロロ−3−インドキシル−2−アセトアミド−2−デオキシ−β−D−グルコピラノシド等が挙げられ、このうち鑑別性の点から5−ブロモ−4−クロロ−3−インドキシル−β−D−グルコピラノシド(X−β−グルコシド)が好ましい。
【0008】
かかるβ−グルコシダーゼ基質の培地中の含有量は、基質により異なるが、0.01〜10g/L、特に0.01〜0.6g/Lであるのが検出性の点で好ましい。
【0009】
グラム陽性菌抗菌物質は、検体中のグラム陽性菌の生育を阻害する目的で培地に添加される。これにより、ビブリオ属等を含むグラム陰性菌のみが生育し得ることとなる。当該グラム陽性菌抗菌物質としては、バンコマイシン、リストセチン、及びこれらの塩等が挙げられ、このうち、培地中における安定性の点からバンコマイシン又はその塩が好ましい。
【0010】
グラム陽性菌抗菌物質の培地中の含有量は、グラム陽性菌の生育が阻害される量であればよく、用いる抗菌物質の種類によって異なるが、0.0001〜1g/L、特に0.001〜0.1g/Lが好ましい。
【0011】
本発明の培地には、腸炎ビブリオの生育を促進し、他の菌の生育を抑制することによって、さらに正確に腸炎ビブリオを検出する目的で、無機塩類及び/又は糖類を含有させるのが好ましい。ここで無機塩類としては、塩化ナトリウム、チオ硫酸ナトリウム等の無機酸金属塩;クエン酸鉄アンモニウム、クエン酸ナトリウム等の有機酸金属塩等が挙げられる。このうち、塩化ナトリウム等の無機酸金属塩は、腸炎ビブリオが好塩性細菌であるため、生育を促進するうえで特に好ましい。また、他の無機塩類は、胆汁末、コール酸ナトリウム、デオキシコール酸ナトリウム等の胆汁酸類と併用することによりビブリオ属以外のグラム陰性菌の生育を抑制するため好ましい。ここで、塩化ナトリウム等の無機酸金属塩は本発明培地中に1.00〜50.0g/L、特に5.00〜30.0g/L含有するのが好ましい。有機酸金属塩は、本発明培地中に0.01〜20.0g/L、特に0.50〜10.0g/L含有するのが好ましい。また胆汁酸類は、本発明培地中に0.001〜5.00g/L、特に0.10〜1.00g/L含有するのが好ましい。
【0012】
糖類としては、単糖類及びオリゴ糖類が使用でき、例えばラクトース、シュークロース(白糖)、キシロース、セロビオース、マルトース等が挙げられる。これらの糖類の添加により、腸炎ビブリオ以外の菌によって前記β−グルコシダーゼ基質が利用されてしまうのを防止でき、より正確な検出が可能となるため、好ましい。これら糖類は、本発明培地中に1.00〜50g/L、特に5〜30g/L含有させるのが好ましい。
【0013】
また、本発明の培地には、ペプトン、酵母エキス、獣肉エキス、魚肉エキス等の栄養成分を含有させるのが好ましい。さらに、ピルビン酸ナトリウム、硫酸塩等を添加することもできる。また、腸炎ビブリオは、アルカリ条件下でよく生育するので、本発明培地にはpHを8.0〜9.0にするためのアルカリ剤を含有するのが好ましい。アルカリ剤としては、炭酸ナトリウム、水酸化ナトリウム、ほう酸ナトリウム、3−[(1,1−ジメチル−2−ヒドロキシエチル)アミノ]−2−ヒドロキシプロパン−スルホン酸、N,N−ビス(2−ヒドロキシエチル)グリシン、N−シクロヘキシル−3−アミノプロパンスルホン酸、シクロヘキシルアミノエタンスルホン酸、N−トリス(ヒドロキシメチル)メチル−3−アミノ−プロパンスルホン酸等が挙げられる。
【0014】
本発明培地の形態は特に限定されず、通常の寒天培地の他、シート状簡易培地(例えばメッシュを有する繊維状吸水シートに担持させた構造(特開2000−325072))とすることもできる。
【0015】
本発明培地を用いて、被検体中の腸炎ビブリオを検出するには、当該培地に検体を添加して30〜45℃で18〜24時間培養した後に、コロニーの着色、蛍光等の特性を観察すればよい。
【0016】
本発明培地に適用される検体としては、魚介類等の生鮮食料品、海水、調理場などのふき取り検体等が挙げられるが、これらの検体を予めトリプトソーヤブイヨン培地で培養した培養液やさらにこれを増菌用培地で培養した培養液も用いることができる。
【0017】
【実施例】
次に実施例を挙げて本発明を詳細に説明するが、本発明はこれら実施例に何ら限定されるものではない。
【0018】
実施例1
ペプトン10g、酵母エキス5g、塩化ナトリウム10g、クエン酸ナトリウム10g、クエン酸鉄アンモニウム1g、チオ硫酸ナトリウム6.4g、白糖末20g、乳糖10g、ピルビン酸ナトリウム1g、牛胆汁末0.25g、X−β−グルコシド0.3g、寒天15gを1リットルの精製水に加え20%炭酸ナトリウム水溶液にてpHを8.8に合わせた後、100℃、20分間加温溶解する。溶解後培地が冷めたことを確認し、ろ過滅菌したバンコマイシン塩酸塩を0.02g/Lになるように加え良く撹拌した後、プラスチックシャーレ(90φmm)に20mLずつ分注して培地が固まるまで静置し、本発明の腸炎ビブリオ検出用培地を作製した。
【0019】
試験例1
供試菌株はトリプトソイブイヨン(腸炎ビブリオ及びビブリオ・アルギノリティカスは3%食塩加トリプトソイブイヨン)で24時間前培養したものを用い、これを滅菌生理食塩水(腸炎ビブリオ及びビブリオ・アルギノリティカスは滅菌3%食塩水)で希釈し本発明の腸炎ビブリオ検出用培地に接種した。
接種後35℃で24時間培養したところ、表1に示すように本発明培地上では腸炎ビブリオは青色の発色コロニーを形成し、ビブリオ・アルギノリティカス、ビブリオ・コレラ等は白色のコロニーを形成し、グラム陽性球菌はその発育が阻止された。これにより、本発明培地を用いれば、腸炎ビブリオが正確かつ簡便に検出できることがわかる。
【0020】
【表1】

Figure 0004886122
【0021】
実施例2
実施例1の組成の培地成分を用いて、メッシュを有する繊維状吸水シートに担持させた簡易培地(特開2000−325072公報)実施例1(ヒドロキシプロピルセルロース0.1重量%におけるブドウ糖2g/Lとテトラゾリウムクロライド0.02g/Lを塩化ナトリウム10g/L、クエン酸鉄アンモニウム1g/L、チオ硫酸ナトリウム6.4g/L、白糖末20g/L、乳糖10g/L、ピルビン酸ナトリウム1g/L、牛胆汁末0.25g/L、X−β−グルコシド0.3g/Lに代えて調製)に試験例1と同様にして供試菌株を適用した。その結果、表2に示すように本発明簡易培地によっても、腸炎ビブリオが正確かつ簡便に検出できた。なお、表2には実施例1の寒天培地による結果も併せて示した。
【0022】
【表2】
Figure 0004886122
【0023】
【発明の効果】
本発明培地を用いれば食中毒原因菌として重要な腸炎ビブリオが正確かつ簡便に検出できる。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a medium and a method for detecting Vibrio parahaemolyticus that can detect Vibrio parahaemolyticus important as a causative agent of food poisoning with high accuracy and ease.
[0002]
[Prior art]
Food poisoning caused by Vibrio parahaemolyticus accounts for a large proportion of bacterial food poisoning that occurs annually in Japan. Vibrio parahaemolyticus is resident in seawater, and poisoning occurs by eating seafood. This food poisoning is acute gastroenteritis and is characterized by fever, vomiting, upper abdominal pain, and diarrhea.
[0003]
A TCBS (Thiosulfate citrate bile salts sucrose) agar medium is widely used as a detection medium for Vibrio parahaemolyticus which is a food poisoning causative bacterium. This TCBS agar medium contains sucrose and a pH indicator, whereas Vibrio parahaemolyticus does not use sucrose, whereas Vibrio alginolyticus ( Vibrio alginolyticus ) and Vibrio which belong to the genus Vibrio and cause food poisoning.・ Cholera ( Vibrio cholerae ), etc. uses the property of producing acid using sucrose. That is, the growing bacteria take up a pH indicator into the cells. Therefore, Vibrio parahaemolyticus, etc. that does not use sucrose forms dark green colonies because there is no change in the color tone of the pH indicator, whereas bacteria that produce acid using sucrose change to yellow colonies because the pH indicator turns yellow. It will be.
[0004]
[Problems to be solved by the invention]
However, in the TCBS agar medium, when Vibrio parahaemolyticus and the above-mentioned related bacteria coexist in the specimen, the dark green colonies of Vibrio parahaemolyticus discolor to other colors, so that accurate detection could not be performed.
Accordingly, an object of the present invention is to provide a medium capable of accurately and simply detecting Vibrio parahaemolyticus without causing a color change or the like even when related bacteria belonging to the same Vibrio genus as Vibrio parahaemolyticus coexist.
[0005]
[Means for Solving the Problems]
Therefore, the present inventor has conducted various studies on medium compositions that can accurately detect Vibrio parahaemolyticus not only from bacteria belonging to other genera but also from related bacteria belonging to the same genus. If a medium containing a β-glucosidase substrate having a sex group is used, Gram-positive bacteria do not grow, Vibrio arginoliticus and Vibrio cholera form white colonies, and Vibrio parahaemolyticus is selectively β -Since a colony having characteristics derived from a glucosidase substrate is formed, it was found that Vibrio parahaemolyticus can be detected accurately and simply, and the present invention has been completed.
[0006]
That is, the present invention provides a medium for detecting Vibrio parahaemolyticus containing a β-glucosidase substrate having a detectable free group and an antibacterial substance of Gram-positive bacteria.
The present invention also provides a method for detecting Vibrio parahaemolyticus characterized by detecting the presence or absence of detectable colonies on the medium after inoculating the sample with the specimen and culturing.
[0007]
DETAILED DESCRIPTION OF THE INVENTION
The β-glucosidase substrate having a detectable free group used in the culture medium of the present invention releases a detectable compound such as a chromogenic compound or a fluorescent compound into the medium by the action of β-glucosidase. Yes, for example, a compound in which a chromogen compound or a fluorescent compound and β-glucose are combined, that is, a β-glucopyranoside or a salt thereof that can liberate the chromogen compound or the fluorescent compound. Vibrio arginolyticus and Vibrio cholera, which are related to Vibrio parahaemolyticus, do not secrete β-glucosidase, whereas Vibrio parahaemolyticus secretes β-glucosidase, so this β-glucosidase substrate is degraded by Vibrio parahaemolyticus. In order to release detectable compounds such as chromogenic compounds and fluorescent compounds, Vibrio parahaemolyticus forms detectable colonies such as colored colonies based on chromogenic compounds and fluorescent colonies based on fluorescent compounds. Specific β-glucosidase substrates include 5-bromo-4-chloro-3-indoxyl-β-D-glucopyranoside (X-β-glucoside, blue), 5-bromo-6-chloro-3-indoxyl. -Β-D-glucopyranoside (MAGENTA-β-glucopyranoside, red purple), 5-bromo-6-chloro-3-indolyl-β-D-glucopyranoside (red purple), 6-chloro-3-indolyl-β-D -Glucopyranoside (pink), 5-bromo-3-indolyl-β-D-glucopyranoside, 4-methyl-umbelliferyl-β-D-glucopyranoside, o-nitrophenyl-β-D-glucopyranoside, phenyl-β-D -Glucopyranoside, 3-nitrophenyl-β-D-glucopyranoside, 4-nitrophenyl-β-D-glucopyranoside, 3 And indoxyl-β-glucopyranoside trihydrate, n-heptyl-β-D-glucopyranoside, 5-bromo-4-chloro-3-indoxyl-2-acetamido-2-deoxy-β-D-glucopyranoside, and the like. Of these, 5-bromo-4-chloro-3-indoxyl-β-D-glucopyranoside (X-β-glucoside) is preferable from the viewpoint of distinguishability.
[0008]
The content of the β-glucosidase substrate in the medium varies depending on the substrate, but is preferably 0.01 to 10 g / L, particularly 0.01 to 0.6 g / L from the viewpoint of detectability.
[0009]
The antibacterial substance of gram positive bacteria is added to the medium for the purpose of inhibiting the growth of gram positive bacteria in the specimen. As a result, only gram-negative bacteria including Vibrio can be grown. Examples of the antibacterial substance of Gram-positive bacteria include vancomycin, ristocetin, and salts thereof, among which vancomycin or a salt thereof is preferable from the viewpoint of stability in the medium.
[0010]
The content of the antibacterial substance of Gram-positive bacteria in the medium may be an amount that inhibits the growth of Gram-positive bacteria, and varies depending on the type of antibacterial substance used, but is 0.0001-1 g / L, especially 0.001- 0.1 g / L is preferred.
[0011]
The medium of the present invention preferably contains inorganic salts and / or saccharides for the purpose of more accurately detecting Vibrio parahaemolyticus by promoting the growth of Vibrio parahaemolyticus and suppressing the growth of other bacteria. Examples of inorganic salts include inorganic acid metal salts such as sodium chloride and sodium thiosulfate; organic acid metal salts such as ammonium iron citrate and sodium citrate. Of these, inorganic acid metal salts such as sodium chloride are particularly preferable for promoting growth because Vibrio parahaemolyticus is a halophilic bacterium. In addition, other inorganic salts are preferable because they inhibit the growth of gram-negative bacteria other than Vibrio spp. By using them together with bile acids such as bile powder, sodium cholate and sodium deoxycholate. Here, the inorganic acid metal salt such as sodium chloride is preferably contained in the medium of the present invention in an amount of 1.00 to 50.0 g / L, particularly 5.00 to 30.0 g / L. The organic acid metal salt is preferably contained in the medium of the present invention in an amount of 0.01 to 20.0 g / L, particularly 0.50 to 10.0 g / L. Bile acids are preferably contained in the culture medium of the present invention in an amount of 0.001 to 5.00 g / L, particularly 0.10 to 1.00 g / L.
[0012]
As the saccharide, monosaccharides and oligosaccharides can be used, and examples thereof include lactose, sucrose (sucrose), xylose, cellobiose, and maltose. The addition of these saccharides is preferable because it can prevent the β-glucosidase substrate from being used by bacteria other than Vibrio parahaemolyticus and enables more accurate detection. These saccharides are preferably contained in the medium of the present invention at 1.00 to 50 g / L, particularly 5 to 30 g / L.
[0013]
The medium of the present invention preferably contains nutrient components such as peptone, yeast extract, animal extract, fish extract and the like. Further, sodium pyruvate, sulfate and the like can be added. Moreover, since Vibrio parahaemolyticus grows well under alkaline conditions, it is preferable that the culture medium of the present invention contains an alkaline agent for adjusting the pH to 8.0 to 9.0. Examples of the alkali agent include sodium carbonate, sodium hydroxide, sodium borate, 3-[(1,1-dimethyl-2-hydroxyethyl) amino] -2-hydroxypropane-sulfonic acid, N, N-bis (2-hydroxy And ethyl) glycine, N-cyclohexyl-3-aminopropanesulfonic acid, cyclohexylaminoethanesulfonic acid, N-tris (hydroxymethyl) methyl-3-amino-propanesulfonic acid, and the like.
[0014]
The form of the medium of the present invention is not particularly limited, and may be a sheet-like simple medium (for example, a structure supported on a fibrous water-absorbing sheet having a mesh (Japanese Patent Laid-Open No. 2000-325072)) in addition to a normal agar medium.
[0015]
In order to detect Vibrio parahaemolyticus in a subject using the culture medium of the present invention, the specimen is added to the medium and cultured at 30 to 45 ° C. for 18 to 24 hours, followed by observation of characteristics such as colony coloration and fluorescence. do it.
[0016]
Samples applied to the culture medium of the present invention include fresh foods such as seafood, seawater, wiping samples such as kitchens, etc., but these samples can be cultured in advance in a tryptosoya bouillon medium. A culture solution obtained by culturing this in a medium for enrichment can also be used.
[0017]
【Example】
EXAMPLES Next, although an Example is given and this invention is demonstrated in detail, this invention is not limited to these Examples at all.
[0018]
Example 1
Peptone 10 g, yeast extract 5 g, sodium chloride 10 g, sodium citrate 10 g, ammonium iron citrate 1 g, sodium thiosulfate 6.4 g, sucrose powder 20 g, lactose 10 g, sodium pyruvate 1 g, bovine bile powder 0.25 g, X- Add 0.3 g of β-glucoside and 15 g of agar to 1 liter of purified water, adjust the pH to 8.8 with 20% aqueous sodium carbonate solution, and dissolve by heating at 100 ° C. for 20 minutes. After dissolution, confirm that the medium was cooled, add vancomycin hydrochloride sterilized by filtration to 0.02 g / L and stir well, then dispense 20 mL each into a plastic petri dish (90 mm), and let stand until the medium solidifies. The medium for detecting Vibrio parahaemolyticus of the present invention was prepared.
[0019]
Test example 1
The test strain used was pre-cultured for 24 hours in Tryptosoy bouillon (Vibrio parahaemolyticus and Vibrio arginoliticus was 3% saline tryptic soy bouillon), and this was sterilized with physiological saline (Vibrio parahaemolyticus and Vibrio arginolyticus). Was diluted with sterile 3% saline) and inoculated into the Vibrio parahaemolyticus detection medium of the present invention.
When inoculated at 35 ° C. for 24 hours after inoculation, Vibrio parahaemolyticus forms a blue colored colony and Vibrio arginolyticus, Vibrio cholera and the like form white colonies on the medium of the present invention as shown in Table 1. Gram-positive cocci were prevented from growing. This shows that Vibrio parahaemolyticus can be detected accurately and simply by using the culture medium of the present invention.
[0020]
[Table 1]
Figure 0004886122
[0021]
Example 2
Example 1 (Glucose 2 g / L in 0.1% by weight of hydroxypropyl cellulose) Simple medium (Japanese Patent Laid-Open No. 2000-325072) supported on a fibrous water-absorbing sheet having a mesh using the medium components having the composition of Example 1 And tetrazolium chloride 0.02 g / L, sodium chloride 10 g / L, ammonium iron citrate 1 g / L, sodium thiosulfate 6.4 g / L, sucrose powder 20 g / L, lactose 10 g / L, sodium pyruvate 1 g / L, The test strain was applied in the same manner as in Test Example 1 to 0.25 g / L of bovine bile powder and prepared in place of 0.3 g / L of X-β-glucoside. As a result, as shown in Table 2, Vibrio parahaemolyticus could be detected accurately and simply by the simple medium of the present invention. Table 2 also shows the results of the agar medium of Example 1.
[0022]
[Table 2]
Figure 0004886122
[0023]
【Effect of the invention】
If the culture medium of the present invention is used, Vibrio parahaemolyticus important as a food poisoning bacterium can be detected accurately and simply.

Claims (3)

下記の成分(A)、(B)、(C)、(D)及び(E)
(A)検出可能な色原体化合物又は蛍光性化合物を遊離し得るβ−グルコピラノシド又はその塩を有するβ−グルコシダーゼ基質、及び
(B)バンコマイシン、リストセチン及びこれらの塩から選ばれるグラム陽性菌抗菌物質
(C)塩化ナトリウム及びチオ硫酸ナトリウム
(D)クエン酸ナトリウム又はクエン酸鉄アンモニウム
(E)胆汁酸類
を含有する腸炎ビブリオ検出用培地。
The following components (A), (B), (C) , ( D) and (E)
(A) a β-glucosidase substrate having β -glucopyranoside or a salt thereof capable of releasing a detectable chromogenic compound or fluorescent compound , and (B) a gram-positive bacterial antibacterial substance selected from vancomycin, ristocetin and salts thereof (C) Sodium chloride and sodium thiosulfate (D) Sodium citrate or iron ammonium citrate
(E) A medium for detecting Vibrio parahaemolyticus containing bile acids.
さらに、糖類を含有するものである請求項1記載の腸炎ビブリオ検出用培地。  Furthermore, the culture medium for Vibrio parahaemolyticus detection of Claim 1 which contains saccharides. 色原体化合物又は蛍光性化合物を遊離し得るβ−グルコピラノシド又はその塩が、下記の化合物群αから選ばれるものである請求項1又は2記載の腸炎ビブリオ検出用培地。
[化合物群α]
5−ブロモ−4−クロロ−3−インドキシル−β−D−グルコピラノシド、5−ブロモ−6−クロロ−3−インドキシル−β−D−グルコピラノシド、5−ブロモ−6−クロロ−3−インドリル−β−D−グルコピラノシド、6−クロロ−3−インドリル−β−D−グルコピラノシド、5−ブロモ−3−インドリル−β−D−グルコピラノシド、4−メチル−ウンベリフェリル−β−D−グルコピラノシド、o−ニトロフェニル−β−D−グルコピラノシド、フェニル−β−D−グルコピラノシド、3−ニトロフェニル−β−D−グルコピラノシド、4−ニトロフェニル−β−D−グルコピラノシド、3−インドキシル−β−グルコピラノシドトリハイドレート、n−ヘプティル−β−D−グルコピラノシド、5−ブロモ−4−クロロ−3−インドキシル−2−アセトアミド−2−デオキシ−β−D−グルコピラノシド
The medium for detecting Vibrio parahaemolyticus according to claim 1 or 2 , wherein β-glucopyranoside or a salt thereof capable of releasing a chromogenic compound or a fluorescent compound is selected from the following compound group α.
[Compound group α]
5-bromo-4-chloro-3-indoxyl-β-D-glucopyranoside, 5-bromo-6-chloro-3-indoxyl-β-D-glucopyranoside, 5-bromo-6-chloro-3-indolyl- β-D-glucopyranoside, 6-chloro-3-indolyl-β-D-glucopyranoside, 5-bromo-3-indolyl-β-D-glucopyranoside, 4-methyl-umbelliferyl-β-D-glucopyranoside, o- Nitrophenyl-β-D-glucopyranoside, phenyl-β-D-glucopyranoside, 3-nitrophenyl-β-D-glucopyranoside, 4-nitrophenyl-β-D-glucopyranoside, 3-indoxyl-β-glucopyranoside trihydrate N-heptyl-β-D-glucopyranoside, 5-bromo-4-chloro-3-indoxy -2-acetamido-2-deoxy-beta-D-glucopyranoside
JP2001165144A 2001-05-31 2001-05-31 Vibrio parahaemolyticus detection medium Expired - Lifetime JP4886122B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001165144A JP4886122B2 (en) 2001-05-31 2001-05-31 Vibrio parahaemolyticus detection medium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001165144A JP4886122B2 (en) 2001-05-31 2001-05-31 Vibrio parahaemolyticus detection medium

Publications (2)

Publication Number Publication Date
JP2002355091A JP2002355091A (en) 2002-12-10
JP4886122B2 true JP4886122B2 (en) 2012-02-29

Family

ID=19007853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001165144A Expired - Lifetime JP4886122B2 (en) 2001-05-31 2001-05-31 Vibrio parahaemolyticus detection medium

Country Status (1)

Country Link
JP (1) JP4886122B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885912B1 (en) * 2005-05-18 2007-07-13 Biomerieux Sa REACTIONAL MEDIUM FOR BACTERIA VIBRIO
JP4681386B2 (en) * 2005-07-29 2011-05-11 日水製薬株式会社 Simple medium and microorganism detection method
JP2012139138A (en) * 2010-12-28 2012-07-26 Nissui Pharm Co Ltd Detection method of vibrio parahemolyticus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517896D0 (en) * 1985-07-16 1985-08-21 Technology Licence Co Ltd Monoclonal antibodies
GB8912330D0 (en) * 1989-05-30 1989-07-12 Wellcome Found Live vaccines
FR2708286B1 (en) * 1993-07-28 1995-10-20 Rambach Alain Method of identifying microorganisms with at least two chromogens.
FR2747394B1 (en) * 1996-04-15 1998-07-03 Rambach Alain CULTURE MEDIUM FOR THE EVIDENCE OF ENTEROHEMORRAGIC E. BACTERIA BACTERIA, AND METHOD FOR ITS EVIDENCE
JP4574787B2 (en) * 1999-03-23 2010-11-04 カゴメ株式会社 How to control bacterial wilt of plants
JP4334067B2 (en) * 1999-06-30 2009-09-16 栄研化学株式会社 E. coli O26 separation medium

Also Published As

Publication number Publication date
JP2002355091A (en) 2002-12-10

Similar Documents

Publication Publication Date Title
US5210022A (en) Method test media and chromogenic compounds for identifying and differentiating general coliforms and Escherichia coli bacteria
US5726031A (en) Test media and quantitative method for identification and differentiation of biological materials in a test sample
US6350588B1 (en) Test media and quantitative or qualitative method for identification and differentiation of biological materials in a test sample
EP0961834B1 (en) Identification of salmonella
EP0954560B1 (en) Method and medium for detecting vancomycin-resistant enterococcus
JP2008545382A (en) Chromogenic plating medium for identification of Enterobacter sakazaki
US9181575B2 (en) Detection and enumeration of microorganisms
CA2603367C (en) Test media and quantitative or qualitative method for identification and differentiation of biological materials in a test sample
CA2570206C (en) Test media and quantitative or qualitative method for identification and differentiation of biological materials in a test sample
JP4886122B2 (en) Vibrio parahaemolyticus detection medium
WO2003097856A2 (en) Plating media
JP4334067B2 (en) E. coli O26 separation medium
JP2008539780A (en) Reaction medium for Vibrio bacteria
US6699685B1 (en) Method, test media and chromogenic compounds for identifying and differentiating general coliforms and escherichia coli bacteria
US6087156A (en) Method for isolation and identification of Escherichia coli 0157:H7 and plating media for said process
JP2006521803A (en) Medium for detection and / or identification of microorganisms
JP2009000002A (en) Culture medium for detecting microorganisms
JP2004321058A (en) Medium for detecting vibrio parahemolyticus
JP2009544277A (en) Improved selection plate medium
JP2012139138A (en) Detection method of vibrio parahemolyticus
JP2013116053A (en) Medium for detecting enterohemorrhagic escherichia coli

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080110

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20080110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100629

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100824

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110705

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110812

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110906

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111024

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20111108

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111206

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111209

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141216

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4886122

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term